Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Manufactured by
China
Guangzhou Biotron Technology Co., Ltd. is a Chinese manufacturer of in vitro diagnostic (IVD) products, specializing in molecular diagnostics (multiplex PCR platforms), point-of-care testing (POCT), pathology diagnostics, and tumor liquid biopsy systems. Their product lines include respiratory pathogen detection panels, HPV testing, tuberculosis IGRA assays, and circulating tumor cell (CTC) detection systems. The company also offers CDMO services for diagnostic product development.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Diatech Pharmacogenetics srl
Italy · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 3 relevant products
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 5 relevant products
CheMOnitor Ltd.
Hungary · 2 relevant products
shanghai rendu biotechnology co.,ltd.
China · 2 relevant products
STRATEC/Diatron
Germany · 1 relevant product
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
DMB Diagnostics
Germany · 2 relevant products
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 97 closest product alternatives
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
Diatech Pharmacogenetics srl · Italy
Molecular testing service for monitoring deep response in chronic myeloid leukemia patients from diagnosis through treatment follow-up. Utilizes genomic sequencing and variant analysis to track disease progression and treatment effectiveness.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic test for guiding cancer treatment selection and predicting therapeutic drug response. Utilizes DNA methylation analysis to optimize personalized cancer treatment strategies.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test providing precise tumor subtyping for improved treatment stratification. Supports personalized oncology management and therapeutic decision-making.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for cancer detection and tumor marker analysis. Supports early detection of various cancer types.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying genetic biomarkers that predict treatment response in cancer patients. Guides selection of targeted therapies and treatment protocols.
CheMOnitor Ltd. · Hungary
An in vitro diagnostic blood test designed to predict chemotherapy effectiveness in lung cancer patients at an early stage, before full treatment cycles are completed. The test analyzes N-glycan profiles using ultra-high resolution glycomics combined with AI-based data interpretation to provide oncologists with actionable treatment response predictions.
shanghai rendu biotechnology co.,ltd. · China
Specialized molecular test for monitoring therapeutic efficacy through detection and quantification of messenger RNA. This test supports treatment response assessment and therapeutic adjustment in clinical practice.
STRATEC/Diatron · Germany
In-vitro diagnostic test for detecting tumor markers and cancer-related antigens in blood and other biological samples. The test aids in cancer screening, diagnosis, and treatment monitoring.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for detection of cancer biomarkers in blood and body secretions. Identifies biomolecules produced and released by cancer cells for screening and monitoring purposes.
DMB Diagnostics · Germany
A research-use-only diagnostic test that isolates and analyzes circulating tumour cells from a single blood draw. Provides data on tumour biology and potential therapeutic response without requiring tissue biopsy.
85 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products